Literature DB >> 8031239

The entry of Junin virus into Vero cells.

V Castilla1, S E Mersich, N A Candurra, E B Damonte.   

Abstract

The entry mechanism of Junin virus (JV) into Vero cells was studied analyzing the effect of lysosomotropic compounds and acid pH on JV infection. Ammonium chloride, amantadine, chlorpheniramine and procaine inhibited JV production. The action of ammonium chloride was exerted at early times of infection. Virus internalization was inhibited and viral protein expression was not detected. When the extracellular medium was buffered at low pH, the ammonium chloride induced block on JV infection was overcome. Furthermore, JV was able to induce fusion of infected cells at pH 5.5 leading to polykaryocyte formation. Taken together, these results demonstrate that JV entry occurs through an endocytic mechanism requiring a low pH dependent membrane fusion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031239      PMCID: PMC7087180          DOI: 10.1007/bf01321064

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  pH-dependent solubility shift of rubella virus capsid protein.

Authors:  C A Mauracher; S Gillam; R Shukin; A J Tingle
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

2.  Argentine hemorrhagic fever.

Authors:  M C Weissenbacher; R P Laguens; C E Coto
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

3.  Epitope model of tick-borne encephalitis virus envelope glycoprotein E: analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH.

Authors:  F Guirakhoo; F X Heinz; C Kunz
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

4.  Early events in arenavirus replication are sensitive to lysosomotropic compounds.

Authors:  S E Glushakova; I S Lukashevich
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Association between the pH-dependent conformational change of West Nile flavivirus E protein and virus-mediated membrane fusion.

Authors:  T Kimura; A Ohyama
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

6.  Reduced virulence of a Junin virus mutant is associated with restricted multiplication in murine cells.

Authors:  L A Scolaro; S E Mersich; E B Damonte
Journal:  Virus Res       Date:  1989-08       Impact factor: 3.303

7.  The effects of oligosaccharide trimming inhibitors on glycoprotein expression and infectivity of Junin virus.

Authors:  A M Silber; N A Candurra; E B Damonte
Journal:  FEMS Microbiol Lett       Date:  1993-05-01       Impact factor: 2.742

8.  Kinetics of endosome acidification detected by mutant and wild-type Semliki Forest virus.

Authors:  M C Kielian; M Marsh; A Helenius
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

9.  Membrane fusion process of Semliki Forest virus. I: Low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells.

Authors:  J M Wahlberg; H Garoff
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

10.  Attenuation of murine coronavirus infection by ammonium chloride.

Authors:  L Mizzen; A Hilton; S Cheley; R Anderson
Journal:  Virology       Date:  1985-04-30       Impact factor: 3.616

View more
  28 in total

1.  Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP.

Authors:  Magali E Droniou-Bonzom; Therese Reignier; Jill E Oldenburg; Alex U Cox; Colin M Exline; Jessica Y Rathbun; Paula M Cannon
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

2.  Role of the stable signal peptide of Junín arenavirus envelope glycoprotein in pH-dependent membrane fusion.

Authors:  Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.

Authors:  Yi-Ying Chou; Christian Cuevas; Margot Carocci; Sarah H Stubbs; Minghe Ma; David K Cureton; Luke Chao; Frances Evesson; Kangmin He; Priscilla L Yang; Sean P Whelan; Susan R Ross; Tom Kirchhausen; Raphaël Gaudin
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

4.  Sodium hydrogen exchangers contribute to arenavirus cell entry.

Authors:  Masaharu Iwasaki; Nhi Ngo; Juan C de la Torre
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.

Authors:  Jessica Y Rathbun; Magali E Droniou; Robert Damoiseaux; Kevin G Haworth; Jill E Henley; Colin M Exline; Hyeryun Choe; Paula M Cannon
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

6.  Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.

Authors:  Nhi Ngo; Kristina Schimmelpfeng Henthorn; Maria Isabel Cisneros; Beatrice Cubitt; Masaharu Iwasaki; Juan C de la Torre; Juan Lama
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

7.  Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Authors:  Masaharu Iwasaki; Shuzo Urata; Yoshitake Cho; Nhi Ngo; Juan C de la Torre
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

8.  Junín Virus Promotes Autophagy To Facilitate the Virus Life Cycle.

Authors:  Julieta S Roldán; Nélida A Candurra; María I Colombo; Laura R Delgui
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

9.  Low-pH-induced fusion of Vero cells infected with Junin virus.

Authors:  V Castilla; S E Mersich
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 10.  Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.

Authors:  Sheli R Radoshitzky; Jens H Kuhn; Fabian de Kok-Mercado; Peter B Jahrling; Sina Bavari
Journal:  Expert Opin Drug Discov       Date:  2012-05-19       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.